An extended study in the clinical evaluation of direct oral anticoagulants

An extended study in the clinical evaluation of direct oral anticoagulants: DIRECT-Extend study - DIRECT-Extend study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050585

Enrollment

6900

Registered

2023-03-15

Start date

2022-01-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: non-valvular AF patients treated with DOAC

Exclusion criteria

Exclusion criteria: Patients who are considered inappropriate to include in the study by physicians.

Design outcomes

Primary

Measure	Time frame
all-cause death, myocardial infarction, stroke, bleeding, gastrointestinal symptoms, heart failure hospitalization, C-reactive protein, catheter ablation	—

Countries

Japan

Contacts

Public ContactYohei Sotomi

Osaka University Graduate School of Medicine Department of Cardiovascular Medicine

sotomi.yohei.med@osaka-u.ac.jp06-6879-3640

Outcome results